FEED
ENvue Medical, Inc.
NASDAQ · Healthcare · Medical - Specialties · US
$4.03
+5.22%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.9M | 2.6M | 2.6M | 2.3M | 752.0K |
| Cost of Revenue | 2.4M | 2.4M | 1.1M | 746.0K | 585.0K |
| Gross Profit | (502.0K) | 153.0K | 1.5M | 1.5M | 167.0K |
| Operating Expenses | |||||
| R&D Expense | 1.2M | 1.8M | 909.0K | 185.0K | 283.0K |
| SG&A Expense | 13.4M | 10.1M | 4.2M | 4.8M | 4.9M |
| General & Admin Expense | 6.5M | 7.6M | 3.5M | 3.9M | 3.9M |
| Selling & Marketing Expense | 2.2M | 2.5M | 720.0K | 864.0K | 965.0K |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 14.6M | 11.9M | 5.1M | 5.0M | 5.2M |
| Cost and Expenses | 17.0M | 14.3M | 6.1M | 5.7M | 5.8M |
| Operating Income (EBIT) | (15.1M) | (11.7M) | (3.6M) | (3.4M) | (5.0M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 247.0K | 288.0K | 135.0K | 246.0K | 347.0K |
| Net Interest Income | (247.0K) | (288.0K) | (135.0K) | (246.0K) | (347.0K) |
| Other Non-Op Income/Expense | (6.3M) | (6.8M) | (104.0K) | (246.0K) | (401.0K) |
| Non-Operating Income (excl Interest) | 301.0K | 6.8M | 104.0K | 111.0K | 401.0K |
| EBT (Pre-Tax Income) | (21.4M) | (18.5M) | (3.7M) | (3.7M) | (5.4M) |
| Income Tax Expense | (353.0K) | (307.0K) | 19.0K | 29.0K | 35.0K |
| Bottom Line | |||||
| Net Income | (21.0M) | (18.2M) | (3.7M) | (3.7M) | (5.4M) |
| Earnings from Cont. Ops | (21.1M) | (18.2M) | (3.7M) | (3.7M) | (5.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (49.2M) | (16.8M) | (3.7M) | (3.7M) | (5.4M) |
| Per Share | |||||
| Basic EPS | ($82,757.16) | ($234.48) | ($1,647.60) | ($2,799.00) | ($5,065.68) |
| Diluted EPS | ($82,757.16) | ($234.48) | ($1,647.60) | ($2,799.00) | ($5,065.68) |
| Revenue Per Share | $3.75 | $35.69 | $1,137.39 | $1,721.72 | $699.53 |
| Shares | |||||
| Basic Shares Outstanding | 513104 | 71536 | 2249 | 1326 | 1075 |
| Diluted Shares Outstanding | 513104 | 71536 | 2249 | 1326 | 1075 |
| Profitability Metrics | |||||
| EBITDA | (14.4M) | (17.6M) | (3.7M) | (3.5M) | (5.4M) |
| D&A | 951.0K | 897.0K | 1.0K | 1.0K | 1.0K |
| EBIT | (15.4M) | (18.5M) | (3.7M) | (3.5M) | (5.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026